SCHEMBL8316042

SCHEMBL8316042

COCC(=O)NC1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(Cl)cc4)n3)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 11/20 0.49
CHUK O15111 8/20 0.49
IKBKG Q9Y6K9 7/20 0.49
PIK3CA P42336 2/20 0.49
PIK3CB P42338 2/20 0.49
PIK3CG P48736 2/20 0.49
CCNK O75909 1/20 0.47
CDK12 Q9NYV4 1/20 0.47
NOS3 P29474 1/20 0.47
NOS1 P29475 1/20 0.47
NOS2 P35228 1/20 0.47
CDK1 P06493 2/20 0.46
CDK2 P24941 1/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
RECQL P46063 1/20 0.44
BLM P54132 1/20 0.44
PRKCZ Q05513 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14021651 0.92 IKBKB (0.50) IKBKBCHUKIKBKGCCNKCDK12
SCHEMBL4074601 0.88 IKBKB (0.50) IKBKBCHUKIKBKGPIK3CAPIK3CB
SCHEMBL14063844 0.86 PIK3CA (0.54) IKBKBCHUKIKBKGPIK3CAPIK3CB
SCHEMBL14063766 0.85 IKBKB (0.51) IKBKBCHUKIKBKGPIK3CAPIK3CB
SCHEMBL8312629 0.85 IKBKB (0.56) IKBKBCHUKIKBKGPIK3CAPIK3CB
SCHEMBL8308337 0.85 NAMPT (0.51) IKBKBCHUKIKBKGPIK3CAPIK3CB
SCHEMBL8312581 0.85 CDK1 (0.58) IKBKBCHUKIKBKGPIK3CAPIK3CB
SCHEMBL13590857 0.84 CDK1 (0.54) IKBKBCHUKIKBKGPIK3CAPIK3CB
SCHEMBL11924743 0.84 GRM5 (0.60) IKBKBCHUKIKBKGPIK3CAPIK3CB
SCHEMBL11924740 0.84 MTOR (0.51) IKBKBCHUKIKBKGPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 WO disclosed